Certification & Communication 

Clinical study publication

The year 2021 sees the medical recognition of the work of Natacha CHETRITT-BONNEYRAT with the publication by the international and scientific Journal of Hearing Science of the clinical study on the results obtained through the use of the ØREBLUE® therapeutic protocol on a sample of patients.

Journal Of Hearing Science.png

New medical device

The Nouvelle-Aquitaine Région acknowledges its recognition and financial support to the research and devlopment and medical innovation project of the Mayfair Developments company owned by Natacha Chetritt-Bonneyrat, audiologist in La Rochelle, for the miniaturization of the medical device dedicated to the ØREBLUE® method in the management of patients suffering from tinnitus and hyperacusis.


The Sud-Ouest newspaper related it in its December 3, 2019 edition.


Registration ANSM

Receipt of registration declaration to the ANSM for the medical device dedicated to the ØREBLUE® method for the treatment of patients suffering from symptoms of tinnitus and hyperacusis.


Standard ISO 13485:2016

ISO 13485 is an international quality management standard that allows the implementation of regulatory requirements for medical devices and related services.

BSI Logo CMYK (002).png

CE Médical Device Class IIa

The Medical CE according to the European Directive 93/42 / EEC Medical Devices is the official recognition that the certified device meets the safety and performance requirements imposed on health equipment, and guarantees that the benefit / risk has been clearly demonstrated.

BSI Logo CMYK (002).png

Abstract Clinic Study

Abstract of the retrospective clinical study published on March 21, 2019 by

Dr. Gabrielle Cremer.

Study demonstrating the performance and safety of the device in the treatment of tinnitus and hyperacusis.

Press Release

Mayfair Developments SAS Press Release
Presentation of the ØREBLUE® method to health professionals and

the medical profession. March 22, 2019